health innovation manchester · 22 universities within one hour’s drive of greater manchester...

2
KEY FACTS Access to 20 million consumers within two hour’s drive. Over 30 NHS organisations and a population of 11 million within an hour’s drive. Home to the National Institute for Health and Clinical Excellence (NICE). City of firsts, the birthplace of the Industrial Revolution, the world’s first computer, test tube baby and the world’s first large scale, real-world clinical trial. Manchester is a city of medical and healthcare pioneers. Manchester is one of only four Health eResearch Centres forming the UK Farr Institute. First UK city to be awarded the prestigious title of European City of Science in 2016. With over 45,000 patients recruited annually Manchester is England’s most successful clinical trial recruitment site. HEALTH INNOVATION MANCHESTER Companies in the wider region include, AstraZeneca, Baxter, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Hitachi, Hologic, Intertek, Novartis, Qiagen, Sanofi, Teva, Thermofisher and Waters Corporation. The University of Manchester boasts 25 Nobel Prize Winners. Home to over 2,000 foreign-owned companies. Home to over 260 biomedical companies who employ over 3,100 people. 22 universities within one hour’s drive of Greater Manchester giving access to over 472,000 students. MANCHESTER: WORKING TOGETHER TO DELIVER INNOVATION As a location for top global pharmaceutical, MedTech and biotech companies, Manchester has a proven track record in establishing partnerships between industry, academia and the NHS. The city is home to an exceptional integrated health innovation infrastructure that scopes, validates and creates partnerships to address unmet medical needs. These organisations provide invaluable expertise and support for businesses to navigate and optimise pathways to adoption and procurement. Please come and speak to our partners for more information. Manchester Science Partnerships (MSP) Manchester Science Partnerships is home to a unique community of scientists, innovators, investors and entrepreneurs and actively supports innovative companies in the science and technology sectors. Putting collaboration first and providing access to specialist finance, talent, markets, networks and investors enables MSP to support the acceleration of business growth through innovation. MSP’s unique partnerships across the science and technology sectors include universities, the NHS, local government, health organisations and industry bodies such as BioNow and the BioIndustry Association. As the UK’s leading science and technology park operator, with five campuses across North West England, MSP is home to more than 300 high growth businesses and offers everything from specialist incubation centres to bespoke build laboratories and international centres of R&D excellence. MSP’s unique approach and unrivalled connections enable companies in the MSP community to survive, grow, and thrive better than the local or national average – turning great ideas into commercial reality. mspl.co.uk @TweetsbyMSP MIDAS MIDAS is Manchester’s inward investment agency. They drive the global business marketing of Manchester as a world-class location for business and deliver an extensive package of expert, complimentary and confidential advice for location consultants and potential investors. MIDAS provides after care to recent investors and works closely with those foreign-owned companies already located in Greater Manchester, creating new jobs and increasing productivity. Manchester has been recognised as Europe’s top city for business competitiveness, an accolade which Manchester has won four times consecutively (KPMG) and the fastest growing and most economically productive city in the UK (Lambert Smith Hampton). Working in partnership with the ten local authorities of Greater Manchester, MIDAS provides services such as investment case development, market intelligence, sourcing property solutions and advice on recruitment and training. investinmanchester.com @MIDAS_MCR GM AHSN GM AHSN is one of 15 Academic Health Science Networks across England spreading innovation, improving health and generating economic growth. As the only bodies that connect NHS and academic organisations, local authorities, the third sector and industry, AHSNs are catalysts that create the right conditions to facilitate change across whole health and social care economies, with a clear focus on improving outcomes for patients. Greater Manchester AHSN brings together 34 members comprising of NHS providers, commissioners and universities across Greater Manchester, East Lancashire and East Cheshire covering a population of around 3 million. GM AHSN's ambition is to deliver a step change in health outcomes and to contribute to Greater Manchester's strategy for growth enabling $3 billion of wealth creation over five years via industry partnership, supporting SMEs and helping to create a healthier population. www.gmahsn.org @gm_ahsn Manchester Metropolitan University (MMU) In the 2014 Research Excellence Framework, MMU was recognised as a top ‘new’ university for health research, which is independently rated as internationally excellent and world leading. MMU is currently assessing different technology options for people with dementia. These technologies support independent living in the community, utilising GPS tracking and enabling the person with dementia or their carer to contact each other in case of an emergency. The University has developed techniques to produce rapid 3D printed models which are The University of Manchester I 3 Ltd – The University’s Innovation Company. UMI 3 is wholly owned by The University of Manchester which has over a 25 year history of IP commercialisation. UMIP’s role is to bring as much of the University’s ground-breaking inventions and software, as is relevant, into the commercial world. This is principally achieved by attracting entrepreneurs, investors and corporate venture partners to our campus and Innovation Centre and then, through engagement with their academic colleagues, licensing or spinning out companies. umip.com @UMIPnews University of Manchester The University of Manchester is the UK's largest single- site university and a founder member of Health Innovation Manchester (HIM). The University's aim is to be the partner of choice for companies seeking academic collaborations in biomedical sciences. Whatever the relationship, there is a focus on well-managed, quick, and fair negotiations to lessen the barriers between the University and industrial partners. For The University of Manchester, the collaborations enabled by this way of working are about more than securing a revenue stream—they are central to how the University defines itself and its relationship with the wider world. bmh.manchester.ac.uk/connect/business/ @OfficialUoM tailored to represent exact configurations for each patient. The models are used for diagnosis and pre-surgical planning thereby significantly reducing anaesthetic time and the complexity of operations, whilst improving patient outcomes. The University conducts innovative research around physiotherapy, activity, and the musculoskeletal system. For example, on combatting deterioration associated with ageing, the results of which have been used to develop guidelines for healthy ageing. www.mmu.ac.uk @MMU_HDAW Northern Health Science Alliance (NHSA) The Northern Health Science Alliance (NHSA) is a single portal for industry and investors interested in biomedical research and innovation in the North of England. The NHSA provides benefits for commercial partners, researchers, universities, hospitals, and patients through bringing together the North’s leading universities, NHS teaching hospitals and four Academic Health Science Networks in one health partnership. The NHSA - uniting eight cities and 15 million patients for health and wealth benefit. www.thenhsa.co.uk @The_NHSA Corridor Manchester Home to an exceptional group of knowledge- intensive organisations and businesses operating in the areas of health, higher education, creative industries, advanced materials, low carbon, digital and financial services. On course to be a top five distinctive and remarkable innovation district in Europe, Corridor Manchester covers a 243 hectare geography, employs over 63,000 people at a growth rate of 11.8% per annum, generates $4.1 billion in GVA per annum and supports over 70,000 students. Health innovation forms one of the key priority areas for the Corridor Manchester, creating a powerhouse at the heart of Health Innovation Manchester Corridormanchester.com @corridormcr UMIP UMIP is The University of Manchester’s agent for intellectual property commercialisation and is a division of MANCHESTER: HOME OF INNOVATION For more than 200 years Manchester has been putting British innovation firmly on the map. Home to four universities who have a strong track record of working with industry, Manchester provides a climate where innovation can grow and prosper. Manchester is the only UK city region to integrate health and social care and have control of its $8 billion healthcare budget. This provides unique opportunities to improve patient outcomes, test new integrated delivery models, and adopt new systems and technologies. Due to the region’s budgetary control, all related commissioning takes place locally, giving direct access to one of the largest National Health Service (NHS) clusters in the UK. All of this is underpinned by Health Innovation Manchester: a health science system dedicated to speeding the discovery of development and delivery of cutting- edge health solutions. The city is a member of the European Super League of biomedical clusters and is the first UK city to be awarded the prestigious title of European City of Science. Manchester offers not just low costs and excellent international connectivity but also a innovation infrastructure that helps companies gain a foothold in the NHS. Digital Health Manchester is recognised as a leader in digital health. The city is one of only four Health eResearch Centres that make up the UK’s Farr Institute, home to a unique primary, secondary and pharmacy integrated e-Health system and Europe’s flagship Connected Health Ecosystem. The Ecosystem enables accelerated adoption of digital and Connected Health solutions in health and social care in the city. Medical Technology Manchester is one of only two UK centres for Proton Beam Cancer Therapy and has bio research centres in orthopaedics. As a result the city has an unrivalled concentration of mass- spectrometry facilities and companies, including Kratos and the Waters Corporation. The region also offers opportunities to explore the medical applications of advanced materials such as graphene. Precision Medicine Manchester is recognised as Europe’s leading centre for cancer research and care delivery. The city is the home of the UK BioBank, this coupled with the extensive research base in Biomarkers, the Centre for Genomics Medicine Research and the ability to access high quality patient data, all place Manchester as a leading centre to take forward this emerging area. Manchester Airport handles more than 20 million passengers per year and offers direct flights to over 200 destinations including 11 major US cities, UAE, Moscow, Singapore, Hong Kong, Beijing and most European business hubs. Connect to London by rail in just 2 hours. Access to 20 million consumers and 60% of the UK’s business base within two hours’ drive. HELLO Manchester is a service that offers free or discounted office space, professional services as well as preferential hotel and restaurant rates to overseas investors. This ‘soft landing’ initiative enables companies to establish a foothold in Europe’s top city for business competitiveness with minimal risk and cost. All of this is underpinned by a vibrant quality of life and complimentary business support from MIDAS. Contact [email protected] to find out more. HELLO MANCHESTER

Upload: others

Post on 01-Jun-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

KEY FACTS

Access to 20 million consumers within two hour’s drive.

Over 30 NHS organisations and a population of 11 million within an hour’s drive.

Home to the National Institute for Health and Clinical Excellence (NICE).

City of firsts, the birthplace of the Industrial Revolution, the world’s first computer, test tube baby and the world’s first large scale, real-world clinical trial. Manchester is a city of medical and healthcare pioneers.

Manchester is one of only four Health eResearch Centres forming the UK Farr Institute.

First UK city to be awarded the prestigious title of European City of Science in 2016.

With over 45,000 patients recruited annually Manchester is England’s most successful clinical trial recruitment site.

HEALTH INNOVATION MANCHESTER

Companies in the wider region include, AstraZeneca, Baxter, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Hitachi, Hologic, Intertek, Novartis, Qiagen, Sanofi, Teva, Thermofisher and Waters Corporation.

The University of Manchester boasts 25 Nobel Prize Winners.

Home to over 2,000 foreign-owned companies.

Home to over 260 biomedical companies who employ over 3,100 people.

22 universities within one hour’s drive of Greater Manchester giving access to over 472,000 students.

MANCHESTER: WORKING TOGETHER TO DELIVER INNOVATIONAs a location for top global pharmaceutical, MedTech and biotech companies, Manchester has a proven track record in establishing partnerships between industry, academia and the NHS. The city is home to an exceptional integrated health innovation infrastructure that scopes, validates and creates partnerships to address unmet medical needs. These organisations provide invaluable expertise and support for businesses to navigate and optimise pathways to adoption and procurement. Please come and speak to our partners for more information.

Manchester Science Partnerships (MSP) Manchester Science Partnerships is home to a unique community of scientists, innovators, investors and entrepreneurs

and actively supports innovative companies in the science and technology sectors. Putting collaboration first and providing access to specialist finance, talent, markets, networks and investors enables MSP to support the acceleration of business growth through innovation.

MSP’s unique partnerships across the science and technology sectors include universities, the NHS, local government, health organisations and industry bodies such as BioNow and the BioIndustry Association.

As the UK’s leading science and technology park operator, with five campuses across North West England, MSP is home to more than 300 high growth businesses and offers everything from specialist incubation centres to bespoke build laboratories and international centres of R&D excellence.

MSP’s unique approach and unrivalled connections enable companies in the MSP community to survive, grow, and thrive better than the local or national average – turning great ideas into commercial reality.mspl.co.uk @TweetsbyMSP

MIDASMIDAS is Manchester’s inward investment agency. They drive the global business marketing of Manchester as a world-class location for business and deliver an extensive package of expert, complimentary

and confidential advice for location consultants and potential investors. MIDAS provides after care to recent investors and works closely with those foreign-owned companies already located in Greater Manchester, creating new jobs and increasing productivity.

Manchester has been recognised as Europe’s top city for business competitiveness, an accolade which Manchester has won four times consecutively (KPMG) and the fastest growing and most economically productive city in the UK (Lambert Smith Hampton).

Working in partnership with the ten local authorities of Greater Manchester, MIDAS provides services such as investment case development, market intelligence, sourcing property solutions and advice on recruitment and training. investinmanchester.com @MIDAS_MCR

GM AHSNGM AHSN is one of 15 Academic Health Science Networks across England spreading innovation, improving health and generating economic growth. As the only bodies that connect NHS and academic organisations, local authorities, the third sector and industry, AHSNs are catalysts that create the right conditions to facilitate change across whole health and social care economies, with a clear focus on improving outcomes for patients. Greater Manchester AHSN brings together 34 members comprising of NHS providers, commissioners and universities across Greater Manchester, East Lancashire and East Cheshire covering a population of around 3 million. GM AHSN's ambition is to deliver a step change in health outcomes and to contribute to Greater Manchester's strategy for growth enabling $3 billion of wealth creation over five years via industry partnership, supporting SMEs and helping to create a healthier population.www.gmahsn.org @gm_ahsn

Manchester Metropolitan University (MMU)In the 2014 Research Excellence Framework, MMU was recognised as a top ‘new’ university for health research, which is independently rated as internationally excellent and world leading.

MMU is currently assessing different technology options for people with dementia. These technologies support independent living in the community, utilising GPS tracking and enabling the person with dementia or their carer to contact each other in case of an emergency.

The University has developed techniques to produce rapid 3D printed models which are

The University of Manchester I3 Ltd – The University’s Innovation Company. UMI3 is wholly owned by The University of Manchester which has over a 25 year history of IP commercialisation.

UMIP’s role is to bring as much of the University’s ground-breaking inventions and software, as is relevant, into the commercial world. This is principally achieved by attracting entrepreneurs, investors and corporate venture partners to our campus and Innovation Centre and then, through engagement with their academic colleagues, licensing or spinning out companies. umip.com @UMIPnews

University of ManchesterThe University of Manchester is the UK's largest single-site university and

a founder member of Health Innovation Manchester (HIM).

The University's aim is to be the partner of choice for companies seeking academic collaborations in biomedical sciences. Whatever the relationship, there is a focus on well-managed, quick, and fair negotiations to lessen the barriers between the University and industrial partners. For The University of Manchester, the collaborations enabled by this way of working are about more than securing a revenue stream—they are central to how the University defines itself and its relationship with the wider world. bmh.manchester.ac.uk/connect/business/ @OfficialUoM

tailored to represent exact configurations for each patient. The models are used for diagnosis and pre-surgical planning thereby significantly reducing anaesthetic time and the complexity of operations, whilst improving patient outcomes.

The University conducts innovative research around physiotherapy, activity, and the musculoskeletal system. For example, on combatting deterioration associated with ageing, the results of which have been used to develop guidelines for healthy ageing.www.mmu.ac.uk @MMU_HDAW

Northern Health Science Alliance (NHSA)The Northern Health Science Alliance (NHSA) is a single portal for industry and investors interested in biomedical research and innovation in the North of England.

The NHSA provides benefits for commercial partners, researchers, universities, hospitals, and patients through bringing together the North’s leading universities, NHS teaching hospitals and four Academic Health Science Networks in one health partnership.

The NHSA - uniting eight cities and 15 million patients for health and wealth benefit.www.thenhsa.co.uk @The_NHSA

Corridor ManchesterHome to an exceptional group of knowledge-intensive

organisations and businesses operating in the areas of health, higher education, creative industries, advanced materials, low carbon, digital and financial services. On course to be a top five distinctive and remarkable innovation district in Europe, Corridor Manchester covers a 243 hectare geography, employs over 63,000 people at a growth rate of 11.8% per annum, generates $4.1 billion in GVA per annum and supports over 70,000 students. Health innovation forms one of the key priority areas for the Corridor Manchester, creating a powerhouse at the heart of Health Innovation Manchester Corridormanchester.com @corridormcr

UMIPUMIP is The University of Manchester’s agent for intellectual property commercialisation and is a division of

MANCHESTER: HOME OF INNOVATIONFor more than 200 years Manchester has been putting British innovation firmly on the map. Home to four universities who have a strong track record of working with industry, Manchester provides a climate where innovation can grow and prosper.

Manchester is the only UK city region to integrate health and social care and have control of its $8 billion healthcare budget. This provides unique opportunities to improve patient outcomes, test new integrated delivery models, and adopt new systems and technologies. Due to the region’s budgetary control, all related commissioning takes place locally, giving direct access to one of the largest National Health Service (NHS) clusters in the UK. All of this is underpinned by Health Innovation Manchester: a health science system dedicated to speeding the discovery of development and delivery of cutting-edge health solutions.

The city is a member of the European Super League of biomedical clusters and is the first UK city to be awarded the prestigious title of European City of Science. Manchester offers not just low costs and excellent international connectivity but also a innovation infrastructure that helps companies gain a foothold in the NHS.

Digital HealthManchester is recognised as a leader in digital health. The city is one of only four Health eResearch Centres that make up the UK’s Farr Institute, home to a unique primary, secondary and pharmacy integrated e-Health system and Europe’s flagship Connected Health Ecosystem. The Ecosystem enables accelerated adoption of digital and Connected Health solutions in health and social care in the city.

Medical TechnologyManchester is one of only two UK centres for Proton Beam Cancer Therapy and has bio research centres in orthopaedics. As a result the city has an unrivalled concentration of mass-spectrometry facilities and companies, including Kratos and the Waters Corporation. The region also offers opportunities to explore the medical applications of advanced materials such as graphene.

Precision MedicineManchester is recognised as Europe’s leading centre for cancer research and care delivery. The city is the home of the UK BioBank, this coupled with the extensive research base in Biomarkers, the Centre for Genomics Medicine Research and the ability to access high quality patient data, all place Manchester as a leading centre to take forward this emerging area.

Manchester Airport handles more than 20 million passengers per year and offers direct flights to over 200 destinations including 11 major US

cities, UAE, Moscow, Singapore, Hong Kong, Beijing and most European business hubs.

Connect to London by rail in just 2 hours.

Access to 20 million consumers and 60% of the

UK’s business base within two hours’ drive.

HELLO Manchester is a service that offers free or discounted office space, professional services as well as preferential hotel and restaurant rates to overseas investors. This ‘soft landing’ initiative enables companies to establish a foothold in Europe’s top city for business competitiveness with minimal risk and cost. All of this is underpinned by a vibrant quality of life and complimentary business support from MIDAS.

Contact [email protected] to find out more.

HELLO MANCHESTER

WIGAN

BOLTONBURY

ROCHDALE

OLDHAM

TAMESIDE

STOCKPORTTRAFFORD

MANCHESTERSALFORD

M66

M62

M62

M60M61 M60

M60

M60

M62

M602

M56

M67

A627(M)

1 2

3

4

5

6

7

89

10

11 1213

TRUSTECHBased in Citylabs 1.0, TRUSTECH is an NHS organisation that improves healthcare through the development of innovative products and services. TRUSTECH works with innovation from within the NHS, as well as from business, to develop and evaluate technologies for the NHS market and solve unmet medical needs. TRUSTECH has worked with many international Med-Tech companies to help them develop and adapt their technologies for the UK market.trustech.org.uk

NorthWest EHealth (NWEH)NWEH is a not-for-profit partnership between the University of Manchester, Salford Royal NHS Foundation Trust and Salford Clinical Commissioning Group also based in Citylabs 1.0. NWEH develops innovative software that unlocks the value of health and care data for the benefit of patients. They are a trusted and accredited provider of software solutions to the NHS, industry and charities servicing over 300 users and safely managing data for over 700 million patient events.nweh.org.uk

The ChristieThe Christie is renowned as a world pioneer in the care, treatment and research of cancer. The largest single-site cancer centre in Europe, The Christie treats more than 44,000 patients a year and has one of the largest trial portfolios in the UK, with over 550 active clinical trials. cmft.christie.nhs.uk

*Companies located in the Enterprise Zone will benefit from business rate discounts, super-fast broadband and simplified planning procedures.

Airport City Enterprise ZoneThe Enterprise Zone brings together two adjacent development schemes – Airport City and Medipark. The first of its kind in Britain, Airport City is located at Manchester Airport - the UK’s busiest airport outside of London. The £800 million landmark development offers 5m sq ft of Grade A office, retail and leisure accommodation ideal for MedTech manufacturing, biomedical, medical device and pharmaceutical organisations.

Medipark is an advanced health research park adjacent to one of Europe’s largest teaching hospitals as well as the airport. Offering over 500,000 sq ft of offices, laboratories and manufacturing plants, it will provide a home for high-value knowledge intensive life science and healthcare related businesses in a unique setting. airportcity.co.uk

Manchester Science Partnerships (MSP) Central Campus*As the UK's leading science and technology park operator, MSP is home to a diverse community of scientists, innovators, investors and entrepreneurs. MSP's network of connections provides the right environments for innovation to flourish, bringing businesses and people together to transform ideas into commercial reality. MSP’s unique approach offers companies access to finance, markets and talent.

MSP’s Central Campus is situated in the Corridor Manchester Enterprise Zone and is the HQ of CityVerve. This project will deploy technologies that allow for rapid scalability and interoperability, and the virtualisation of data.mspl.co.uk

The MedTECH Centre*The MedTECH Centre is a specialist incubator for businesses and innovators who are developing products and technologies which can help the NHS improve patient care. Located on MSP's Central Campus, the centre provides entrepreneurs the chance to work alongside NHS partners to accelerate new products into the market.mspl.co.uk

The LandingThe Landing is a digital enterprise hub at the heart of MediaCityUK. It provides everything SMEs in the digital health sector need to grow with interactive media labs, UX testing, digital workflow and shared working spaces available onsite. thelanding.org.uk

University of Manchester The University of Manchester is ranked 29th in this year's QS World University Rankings and is the UK’s largest single-site university. The University conducts a wide range of high-quality biomedical science research in collaboration with partners worldwide to search for innovative solutions to some of society’s most pressing problems. manchester.ac.uk

MANCHESTER: THE PERFECT ENVIRONMENT

FOR SUCCESSWhether you require a small incubator or large scale manufacturing,

Manchester has life science facilities designed to support commercialisation, all within close proximity to academic, clinical

centres of excellence and benefiting from our integrated health innovation infrastructure.

Salford Royal NHS Foundation Trust Salford Royal NHS Foundation Trust is England’s only fully e-enabled health trust placing it at the forefront of health informatics. The Trust formed the testbed of the world’s first large-scale, real-world clinical trial – The Salford Lung Study.srft.nhs.uk

Univers 57 / 5 poi tsB

Corridor Manchester* Corridor Manchester is home to a wealth of knowledge intensive organisations operating in the areas of biomedical, pharmaceuticals, precision medicine, clinical trials, EHealth, medical devices and related healthcare.

Co-located in the Corridor are two universities, five specialist hospitals, local government, entrepreneurial, business, cultural assets and an Enterprise Zone. The Corridor is also the site of the UK’s multi-million pound ‘smart city’ Internet of Things demonstrator, CityVerve. The enterprise zone encompasses CMFT and MSP’s Central Campus.corridormanchester.com

Citylabs*MSP's Citylabs campus offers specialist innovation facilities for companies and R&D centres in the heart of the largest clinical academic campus in Europe, bringing clinical, academic and industry partners together to develop more effective health products.

Located on the CMFT site (9), Citylabs 1.0 is a centre of biomedical excellence, offering high-specification flexible office and laboratory space. Building on the success of Citylabs 1.0, Citylabs 2.0 and 3.0 (due to be completed in 2018 and 2020) will provide additional space for health and medical technology businesses to grow and co-create new products in collaboration with the NHS and academia.mspl.co.uk

Central Manchester University Hospital NHS Foundation Trust (CMFT)*Located on Corridor Manchester, CMFT is the leading provider of tertiary and specialist healthcare services in Manchester, treating more than a million patients every year. The five specialist hospitals onsite, include the largest children’s hospital in the UK and a leading centre for genomic medicine. It is home to hundreds of world-class clinicians and academic staff committed to finding the best care and treatments for patients.cmft.nhs.uk

Manchester Metropolitan University Home to over 36,000 students, Manchester Metropolitan University is one of the most extensive higher education centres in Europe and is ranked in the global top 3% of universities. In addition to health, the university educates and trains large numbers of engineers, teachers and legal, business and creative professionals.mmu.ac.uk

Manchester

Health Innovation Manchester

Manchester“Europe’s top city for business competitiveness” KPMG Competitive Alternatives, 2016

“Fastest growing city and most economically productive in the UK”Lambert Smith Hampton City Vitality Index, 2016

“Top 10 Global Destination for FDI” IBM Global Location Trends, 2016

“Best city to live in the UK” The Economist Intelligence Unit, 2016

Contact us to find out how Manchester can be part of your success story.

Phone: +44 (0) 161 237 4470Email: [email protected]: investinmanchester.comTwitter: @midas_mcr